Screening in the UK: making effective recommendations 2016 to 2017 summarises all the screening recommendations made between 1 April 2016 and 31 March 2017 and the evidence behind those recommendations.
screening benefits and risks
Little is known about the effects on a man's quality of life of knowing he has an aneurysm that might eventually grow to a dangerous size that requires treatment.
Early access to sickle cell and thalassaemia screening and the early offer of prenatal diagnosis (PND) is important in giving women and couples time to consider their options.
As part of a wider investigation into why women are tested late, we commissioned the UK Thalassaemia Society (UKTS) and Sickle Cell Society (SCS) to carry out face to face interviews with women and couples who had recent experience of the SCT programme.
Screening folk can be a loyal bunch – either that or it’s a difficult discipline to escape from! A colleague of mine recently reached the amazing milestone of working 30 years in screening, making me reflect on my own career.
The programme will introduce a new improved home test kit for screening from April 2018. It is call a faecal immunochemical test (FIT) and it will replace the guaiac faecal occult blood test (gFOBt). It’s important that GPs and others working in primary care understand this change to the screening programme and its implications for their patients, so here is a brief summary.
The Eklund technique is an internationally recognised method to improve the detection of breast cancer in women with breast implants. It is already used in services in Australia, the USA and some other countries to promote high quality breast screening and …
I've been a quality assurance (QA) advisor since October 2015, having previously worked in the screening and immunisation team for Public Health England.
Group B Streptococcus (GBS) is an important cause of illness in babies, children and elderly adults. It remains the commonest infection that causes serious illness in newborn babies.
A new test will be added to the fetal anomaly screening pathway following an announcement by the Department of Health.